Jianpeng Sheng
-
- Cancer Genomics and Diagnostics 5
- Cancer-related molecular mechanisms research 3
-
- Cancer Immunotherapy and Biomarkers 6
- Pancreatic and Hepatic Oncology Research 5
-
- Immune cells in cancer 7
-
- Ferroptosis and cancer prognosis 3
-
- Nanoplatforms for cancer theranostics 3
-
- Radiomics and Machine Learning in Medical Imaging 3
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Jianpeng Sheng
29 papers receiving 678 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 120
- Oncology 185
- Immunology 136
- Molecular Biology 291
- Hepatology 19
Countries citing papers authored by Jianpeng Sheng
This map shows the geographic impact of Jianpeng Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianpeng Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianpeng Sheng more than expected).
Fields of papers citing papers by Jianpeng Sheng
This network shows the impact of papers produced by Jianpeng Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianpeng Sheng. The network helps show where Jianpeng Sheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianpeng Sheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 27 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 37 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 12 | |
| 13 | 2023 | 0 | |
| 14 | 2023 | 19 | |
| 15 | 2022 | 19 | |
| 16 | 2022 | 28 | |
| 17 | 2022 | 8 | |
| 18 | 2021 | 1 | |
| 19 | 2021 | 9 | |
| 20 | 2018 | 50 |
About Jianpeng Sheng
Jianpeng Sheng is a scholar working on Cancer Research, Oncology and Immunology, having authored 32 papers that have together received 685 indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Ferroptosis and cancer prognosis (3 papers), Cancer-related molecular mechanisms research (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). The work is most often cited by research in Cancer Research (120 citations), Oncology (185 citations) and Immunology (136 citations). Jianpeng Sheng has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Qing Li, Yaqi Mo, Qing Luo, Shan Geng, Hao Luo, Wei Wang, Bo Xu, Lu Wang, Guanbin Song and Xu Han.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.